<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02733705</url>
  </required_header>
  <id_info>
    <org_study_id>TRUS</org_study_id>
    <nct_id>NCT02733705</nct_id>
  </id_info>
  <brief_title>Intravenous Propofol and Fentanyl vs Propofol for Sedation in TRUS Biopsy</brief_title>
  <official_title>A Randomised Controlled Trial Comparing Combined Intravenous Propofol and Fentanyl Versus Intravenous Propofol Alone for Sedation in Patients Undergoing Transrectal Ultrasound-guided (TRUS) Prostate Biopsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nowadays, TRUS biopsy become one of the most popular tests for diagnosis of prostate cancer.
      This procedure causes pain to the patients who does not received the sedative drugs or
      analgesic drugs. There are many ways to reduce pain and inconvenience for the patients, such
      as intravenous propofol, intravenous fentanyl etc. In Siriraj hospital, anesthesiologists
      usually give intravenous propofol with intravenous opioids but the visual analogue score
      after this procedure was average at 0.9-2.9. Furthermore, some systematic reviews have shown
      that there was no difference in pain score between periprostatic nerve block plus opioid and
      periprostatic nerve block only. So, this study is to find out whether opioids is need for
      TRUS biopsy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain assess using Numeric rating scale (NRS) score</measure>
    <time_frame>20 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with hypoxia defined as oxygen saturation &lt;92%</measure>
    <time_frame>60 minutes</time_frame>
    <description>The investigators define hypoxia as oxygen saturation &lt; 92%. The investigators will report as number of episode.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with hypotension, defined as systolic blood pressure &lt;90 mmHg</measure>
    <time_frame>60 minutes</time_frame>
    <description>The investigators define hypotension as systolic blood pressure&lt; 90 mmHg. The investigators will report as number of episode.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>normal saline IV plus propofol infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.5 mcg/kg ideal body weight IV plus propofol infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>normal saline IV</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>fentanyl 0.5 mcg/kg ideal BW</description>
    <arm_group_label>Fentanyl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>propofol infusion</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Fentanyl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 year

          -  Patient American society of anesthesiology physical status I-III.

          -  Scheduled for Transrectal ultrasound-guided prostate biopsy

          -  BMI equal to or less than 30 kg/cm2

        Exclusion Criteria:

          -  Known hypersensitivity to propofol or fentanyl

          -  History of bleeding tendency

          -  Known case of active anal or rectal disease

          -  Unable to rate pain score

          -  History of drug abuse

          -  Chronic opioid use
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sirilak Suksompong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sirilak Suksompong, MD</last_name>
    <phone>66891534806</phone>
    <email>ssuksompong5@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sirilak Suksompong</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sirilak Suksompong, MD</last_name>
      <phone>66891534806</phone>
      <email>sirilak.suk@mahidol.ac.th</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2016</study_first_submitted>
  <study_first_submitted_qc>April 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2016</study_first_posted>
  <last_update_submitted>January 22, 2018</last_update_submitted>
  <last_update_submitted_qc>January 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Sirilak Suksompong</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>TRUS biopsy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

